AEGON Asset Management (UK)’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-139,014
Closed -$2.57M 178
2020
Q4
$2.57M Buy
139,014
+5,039
+4% +$111K 0.04% 144
2020
Q3
$3.35M Buy
+133,975
New +$3.34M 0.07% 100

Other funds holding RCEL

AEGON Asset Management (UK)'s RCEL Position: Q1 2021 in Review

AEGON Asset Management (UK) sold out of Avita Medical (RCEL) in Q1 2021, closing a stake of 139,014 shares — an estimated $2.57M sold.

AEGON Asset Management (UK) first reported a position in RCEL in Q3 2020 and held it in 2 quarters. The position peaked at $3.35M in Q3 2020. 61 funds tracked by Wall St. Rank hold RCEL as of Q1 2021.

  • AEGON Asset Management (UK) reported no remaining Avita Medical position as of Q1 2021 after selling out during the quarter.
  • AEGON Asset Management (UK) sold 139,014 Avita Medical shares in Q1 2021, an estimated $2.57M.
  • AEGON Asset Management (UK) first reported a position in Avita Medical in Q3 2020 and held it in 2 quarters.
  • AEGON Asset Management (UK)'s Avita Medical position peaked at $3.35M in Q3 2020.
  • 61 funds tracked by Wall St. Rank held Avita Medical as of Q1 2021.

Based on AEGON Asset Management (UK)'s 13F filing for Q1 2021, filed 7 May 2021.